Free NAHQ CPHQ Exam Dumps June 2026

The initiative to increase lung cancer screenings for a patient population with a history of smoking falls under secondary prevention123.Secondary prevention aims to reduce the impact of a disease or injury that has already occurred2.This is done by detecting and treating disease or injury as soon as possible to halt or slow its progress2.In the context of healthcare, screenings are a common form of secondary prevention123.They allow for early detection of diseases like lung cancer, especially in high-risk groups such as smokers123.Early detection can lead to more effective treatment and better health outcomes123.

https://www.iwh.on.ca/what-researchers-mean-by/primary-secondary-and-tertiary-prevention

When a physician's readmission rate is significantly higher than their peers, the next step for a quality professional should be toreview a sample of recent individual cases of the physician's readmissions (Option D).This will help identify any patterns or issues that could be contributing to the higher readmission rate12. Reporting the surgeon to the medical board (Option A) is a drastic step that should only be taken if there is evidence of serious misconduct or incompetence. Reviewing the physician's privileges against the procedures performed (Option B) could be useful, but it would not directly address the issue of the high readmission rate. Comparing the physician's readmission rate with peer physicians (Option C) has already been done, as stated in the question.Therefore, the most appropriate next step is to review individual cases to gain a deeper understanding of the reasons for the high readmission rate345.

A clinical pathway/guideline is a tool that helps healthcare providers to deliver evidence-based, patient-centered, and standardized care for a specific condition or population12.

The main goal of aclinical pathway/guideline is to improve the quality and consistency of care, reduce unnecessary variations, optimize outcomes, and enhance patient satisfaction123.

A clinical pathway/guideline is not meant to assist in documentation of care (option A), although it may include documentation requirements as part of the quality improvement process1.

A clinical pathway/guideline is not meant to document practitioner variances (option B), although it may allow for deviations from the recommended care based on individual patient needs and preferences, clinical judgment, and resource availability12.Variances should be monitored and evaluated for their impact on outcomes and quality1.

A clinical pathway/guideline is not meant to ensure precise treatment plans are followed (option D), although it may provide recommendations for specific interventions, tests, or medications based on the best available evidence12.A clinical pathway/guideline should be flexible and adaptable to the local context and the patient's situation12.Reference:1:Clinical Pathways2:NICE clinical guidelines3:Clinical Practice Guidelines

The scatter diagramshows that as the decrease in staffing targets becomes more significant (moving right on the horizontal axis), the incidence of infection goes up (moving up on the vertical axis). This indicates a negative relationship because as one variable increases, the other one decreases. The relationship appears to be strong because the points lie closely to an imaginary line that slopes upwards from left to right, which suggests a consistent trend across the data points.

The data shows that diabetic retinal eye exam rates (60%, 58%, 62%) are consistently below the target (>80%), indicating the current intervention is not achieving the desired outcome.

Option A (Continue the pilot for another quarter): Continuing without reassessment is inefficient, as three quarters of data show no significant progress toward the target, suggesting the intervention needs adjustment.

Option B (Implement the change): Implementation is premature, as the intervention has not met the target, indicating it is not effective enough for broad adoption.

Option C (Review additional data): This is the correct answer. NAHQ CPHQ study materials recommend analyzing additional data (e.g., barriers, process issues, or subgroup performance) to understand why the intervention is failing and inform next steps, aligning with PDSA (Plan-Do-Study-Act) methodology.

Option D (Plan for the next change): Planning the next change is a subsequent step after reviewing data to identify root causes or new strategies.